Letter: evaluation and proposed reclassification of HCC prediction model of Tahata et al. in chronic hepatitis C genotype 4 patient. Authors' reply

Aliment Pharmacol Ther. 2022 Jan;55(2):258-259. doi: 10.1111/apt.16721.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Carcinoma, Hepatocellular* / genetics
  • Genotype
  • Hepacivirus / genetics
  • Hepatitis C, Chronic* / genetics
  • Humans
  • Liver Neoplasms* / genetics